Stock market week-in-review for 5 large GI companies — Nov. 27 to Dec. 1

Here is how five major, publicly traded gastroenterology companies fared in the stock market for the week of Nov. 27 to Dec. 1, 2017.

Advertisement

Note: This data was compiled using Yahoo Finance.

1. Allergan Pharmaceuticals

Opened: $173.59 on Nov. 27
Peaked: $179.85 on Nov. 29
Closed: $169.94 on Dec. 1
Percent change between Nov. 27 and Dec. 1: -2.10 percent

2. Exact Sciences Corp.

Opened: $59.49 on Nov. 27
Peaked: $59.97 on Nov. 30
Closed: $57.95 on Dec. 1
Percent change between Nov. 27 and Dec. 1: -2.58 percent

3. Johnson & Johnson

Opened: $137.51 on Nov. 27
Peaked: $140.53 on Nov. 28
Closed: $139.98 on Dec. 1
Percent change between Nov. 27 and Dec. 1: 1.79 percent

4. Synergy Pharmaceuticals

Opened: $1.89 on Nov. 27
Peaked: $2.10 on Nov. 30
Closed: $2 on Dec. 1
Percent change between Nov. 27 and Dec. 1: 5.82 percent

5. Valeant Pharmaceuticals

Opened: $16.55 on Nov. 27
Peaked: $17.62 on Dec. 1
Closed: $17.25 on Dec. 1
Percent change between Nov. 27 and Dec. 1: 4.22 percent

More articles on gastroenterology: 
5 most read GI/endoscopy stories: Nov. 27-Dec. 1
GI leader to know: Dr. Edward Schirack of Clinical Gastroenterology
Grants increase CRC screening rates at federal health centers

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Register to Attend Webinar

Building a High-Performance Cardiac PET Program: What Health Systems Should Consider

Thursday, July 30
12:00 PM - 1:00 PM CDT

Presenters: Rupa Sanghani, MD, FACC, FASNC, Rush University Medical CenterBrendon Loiselle, CDL Nuclear Technologies

Advertisement

Next Up in GI & Endoscopy

Advertisement

Comments are closed.